• Critical Innovations

Article published in the Journal of Surgical Research shows benefits of F.O.A.M.™ device

An article just published in the Journal of Surgical Research shows impressive benefits with F.O.A.M.™ deployment in a lethal, large-animal model of non-compressible abdominal bleeding. This is the first study to describe the use of a thermoresponsive foam to manage this important injury and it successfully demonstrated proof-of-concept feasibility. The intervention group demonstrated a significantly higher mean arterial pressure and an impressive trend toward improved survival (82% vs. 50% in controls). This injury pattern normally requires emergent surgery from a highly trained surgeon, while the F.O.A.M.™ device aims to shift intervention to earlier providers and settings. See full article here.

79 views0 comments

Recent Posts

See All

Critical Innovations is happy to announce that it recently signed a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Combat Capabilities Development Command Chemical Biologica

Critical Innovations signed a new Cooperative Research and Development Agreement (CRADA) with the Naval Medical Center San Diego / Navy Medicine Readiness and Training Command San Diego. The company i